Predictive Biomarkers and Novel Therapeutic Strategies in Oncology
Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie

France

1 November 2017 - 31 October 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Predictive Biomarkers and Novel Therapeutic Strategies in Oncology published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Predictive Biomarkers and Novel Therapeutic Strategies in Oncology is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

AC FC
3 0.76

Outputs by subject (FC)

Subject AC FC
Life Sciences 3 0.76

1 November 2017 - 31 October 2018

International vs. domestic collaboration by FC

  • 97.13% Domestic
  • 2.87% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by FC (4 total)

  • Predictive Biomarkers and Novel Therapeutic Strategies in Oncology, France
  • Foreign institution
  1. McGill University, Canada (0.38)
    0.34
    0.05
  2. Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) (0.04)
    0.01
    0.03
  3. Cornell University, United States of America (USA) (0.02)
    0.01
    0.01
  4. Karolinska Institute (KI), Sweden (0.01)
    0.01
    0

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Participating institutions

Predictive Biomarkers and Novel Therapeutic Strategies in Oncology is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs